Artikelen door Mithra Pharmaceuticals

Mithra Signs a Binding Term Sheet with the Japanese Leader in Women’s Health Fuji Pharma to Commercialize Donesta® in Japan and ASEAN

Mithra signs a binding term sheet for Donesta® with Fuji Pharma, in line with its strategy to partner out its lead Estetrol-based products Fuji Pharma, the Women’s Health leader in Japan, obtains the rights to commercialize Donesta®, Mithra’s Hormonal Treatment (HT) product candidate based on Estetrol, in Japan and ASEAN. Fuji Pharma intend to extend […]

Mithra Signs a Binding Term Sheet with the Japanese Leader in Women’s Health Fuji Pharma to Commercialize Donesta® in Japan and ASEAN

Mithra signs a binding term sheet for Donesta® with Fuji Pharma, in line with its strategy to partner out its lead Estetrol-based products Fuji Pharma, the Women’s Health leader in Japan, obtains the rights to commercialize Donesta®, Mithra’s Hormonal Treatment (HT) product candidate based on Estetrol, in Japan and ASEAN. Fuji Pharma intend to extend […]

Mithra Signs a Binding Term Sheet with the Japanese Leader in Women’s Health Fuji Pharma to Commercialize Donesta® in Japan and ASEAN

Mithra signs a binding term sheet for Donesta® with Fuji Pharma, in line with its strategy to partner out its lead Estetrol-based products Fuji Pharma, the Women’s Health leader in Japan, obtains the rights to commercialize Donesta®, Mithra’s Hormonal Treatment (HT) product candidate based on Estetrol, in Japan and ASEAN. Fuji Pharma intend to extend […]

Openbaarmaking van een transparantiekennisgeving ontvangen door Mithra Pharmaceuticals NV

Luik, België 09 januari 2017 – Gereglementeerde informatie – Overeenkomstig artikel 14 van de wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen, maakt Mithra Pharmaceuticals NV bekend dat zij verschillende transparantieverklaringen heeft ontvangen. Mithra Pharmaceuticals NV ontving een op 29 december 2016 gedateerde transparantiekennisgeving, waaruit blijkt dat Bart Versluys (Versluys Invest BVBA, […]